Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 17, 2022

BUY
$127.96 - $207.36 $5.4 Million - $8.75 Million
42,200 Added 112.83%
79,600 $16.5 Million
Q4 2021

Feb 15, 2022

SELL
$165.13 - $241.83 $3.91 Million - $5.73 Million
-23,700 Reduced 38.79%
37,400 $6.67 Million
Q3 2021

Nov 16, 2021

BUY
$163.99 - $235.57 $3.26 Million - $4.69 Million
19,900 Added 48.3%
61,100 $12.6 Million
Q2 2021

Aug 16, 2021

BUY
$131.45 - $201.49 $5.21 Million - $7.98 Million
39,600 Added 2475.0%
41,200 $7.82 Million
Q1 2021

May 18, 2021

SELL
$92.73 - $142.05 $769,659 - $1.18 Million
-8,300 Reduced 83.84%
1,600 $208,000
Q4 2020

Feb 17, 2021

SELL
$67.44 - $103.72 $1.56 Million - $2.41 Million
-23,200 Reduced 70.09%
9,900 $1.03 Million
Q3 2020

Nov 17, 2020

BUY
$42.79 - $75.8 $697,477 - $1.24 Million
16,300 Added 97.02%
33,100 $2.51 Million
Q2 2020

Aug 17, 2020

BUY
$27.25 - $47.53 $457,800 - $798,504
16,800 New
16,800 $796,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.